NEWS

Our Latest News

ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices

ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.

ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices

ARCHIMED completes seventh acquisition for NAMSA, the world leader in Medical Device testing services

 March

 27, 

2023

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company – and French market leader – CARSO

 March

 16, 

2023

ARCHIMED buys WiQo, a pioneer in the field of aesthetic medicine

 March

 9, 

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

 October

 7, 

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

 October

 4, 

2022

ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal

 July

 21, 

2022

1 2 3 4 5 … 14
368